These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7866991

  • 1. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS, Nishio K, Ogasawara H, Funayama Y, Ohira T, Saijo N.
    Cancer Res; 1995 Mar 01; 55(5):1075-9. PubMed ID: 7866991
    [Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA.
    Cancer Res; 1992 Oct 15; 52(20):5674-80. PubMed ID: 1327513
    [Abstract] [Full Text] [Related]

  • 4. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
    Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N.
    Cancer Res; 1993 Jul 15; 53(14):3302-7. PubMed ID: 8391922
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS, Jung HY, Yang SK, Kim HR, Min YI.
    Anticancer Res; 1997 Jul 15; 17(5A):3613-6. PubMed ID: 9413212
    [Abstract] [Full Text] [Related]

  • 6. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Jul 15; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 7. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair.
    Bungo M, Fujiwara Y, Kasahara K, Nakagawa K, Ohe Y, Sasaki Y, Irino S, Saijo N.
    Cancer Res; 1990 May 01; 50(9):2549-53. PubMed ID: 2158392
    [Abstract] [Full Text] [Related]

  • 8. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
    Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N.
    Cancer Res; 1991 Jun 15; 51(12):3237-42. PubMed ID: 1645616
    [Abstract] [Full Text] [Related]

  • 9. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA.
    Cancer Res; 1994 Mar 15; 54(6):1497-502. PubMed ID: 8137254
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S, Naito S, Yokomizo A, Kumazawa J, Asakuno K, Kohno K, Kuwano M.
    Cancer Res; 1994 Jun 15; 54(12):3248-52. PubMed ID: 8205547
    [Abstract] [Full Text] [Related]

  • 11. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
    Bando T, Fujimura M, Kasahara K, Matsuda T.
    Anticancer Res; 1998 Jun 15; 18(2A):1085-9. PubMed ID: 9615770
    [Abstract] [Full Text] [Related]

  • 12. Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines.
    Bando T, Kasahara K, Shibata K, Nakatsumi Y, Fujimura M, Matsuda T.
    Anticancer Res; 1994 Jun 15; 14(6B):2727-30. PubMed ID: 7872708
    [Abstract] [Full Text] [Related]

  • 13. In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.
    Hong WS, Saijo N, Sasaki Y, Shinkai T, Eguchi K, Sakurai M, Takahashi H, Nakano H, Nakagawa K, Twentyman PR.
    Jpn J Cancer Res; 1987 Nov 15; 78(11):1274-80. PubMed ID: 3121562
    [Abstract] [Full Text] [Related]

  • 14. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Nov 15; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K, Ishida T, Arioka H, Kurokawa H, Fukuoka K, Nomoto T, Fukumoto H, Yokote H, Saijo N.
    Anticancer Res; 1996 Nov 15; 16(6B):3387-95. PubMed ID: 9042196
    [Abstract] [Full Text] [Related]

  • 16. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K, Ohnoshi T, Ueoka H, Takigawa N, Tabata M, Segawa Y, Shibayama T, Kimura I.
    Anticancer Drug Des; 1992 Dec 15; 7(6):463-70. PubMed ID: 1337430
    [Abstract] [Full Text] [Related]

  • 17. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK, Davey MW, Davey RA.
    Cancer Chemother Pharmacol; 2006 Aug 15; 58(2):256-65. PubMed ID: 16283310
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
    Moritaka T, Kiura K, Ueoka H, Tabata M, Segawa Y, Shibayama T, Takigawa N, Ohnoshi T, Harada M.
    Anticancer Res; 1998 Aug 15; 18(2A):927-33. PubMed ID: 9615743
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A, Weixel K, Saijo N.
    Cell Growth Differ; 1996 Nov 15; 7(11):1507-12. PubMed ID: 8930400
    [Abstract] [Full Text] [Related]

  • 20. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008 Nov 15; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.